These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25887373)

  • 21. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of
    Narang A; Giri A; Gupta S; Garima K; Bose M; Varma-Basil M
    Int J Mycobacteriol; 2017; 6(2):177-183. PubMed ID: 28559521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya.
    Kerubo G; Amukoye E; Niemann S; Kariuki S
    BMC Infect Dis; 2016 Oct; 16(1):583. PubMed ID: 27756241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanism of the synergistic activity of ethambutol and isoniazid against
    Zhu C; Liu Y; Hu L; Yang M; He ZG
    J Biol Chem; 2018 Oct; 293(43):16741-16750. PubMed ID: 30185616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison between bacteriophage-based assay and BACTEC-960 system in detection of ethambutol resistance in Mycobacterium tuberculosis].
    Ma XW; Hu ZY; Wang J; Zhang YR; Cui ZL; Cao XY; Weng XH
    Zhonghua Nei Ke Za Zhi; 2005 Mar; 44(3):202-5. PubMed ID: 15840261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
    Guo N; Wu J; Fan J; Yuan P; Shi Q; Jin K; Cheng W; Zhao X; Zhang Y; Li W; Tang X; Yu L
    Lett Appl Microbiol; 2014 Apr; 58(4):344-9. PubMed ID: 24330002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India.
    Jadaun GP; Das R; Upadhyay P; Chauhan DS; Sharma VD; Katoch VM
    Int J Antimicrob Agents; 2009 May; 33(5):483-6. PubMed ID: 19112008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs against Mycobacterium tuberculosis isolates.
    Coban AY; Akbal AU; Uzun M; Cayci YT; Birinci A; Durupinar B
    Mem Inst Oswaldo Cruz; 2016 Jun; 0(7):0. PubMed ID: 27304025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation at embB codon 306, a potential marker for the identification of multidrug resistance associated with ethambutol in Mycobacterium tuberculosis.
    Cuevas-Córdoba B; Juárez-Eusebio DM; Almaraz-Velasco R; Muñiz-Salazar R; Laniado-Laborin R; Zenteno-Cuevas R
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5455-62. PubMed ID: 26124153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex.
    Rodrigues L; Machado D; Couto I; Amaral L; Viveiros M
    Infect Genet Evol; 2012 Jun; 12(4):695-700. PubMed ID: 21871582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium resistance to antimycobacterial reagent.
    Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L
    Therapie; 1999; 54(5):623-5. PubMed ID: 10667100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid detection of ethambutol-resistant
    Chauhan DS; Sharma R; Parashar D; Das R; Sharma P; Singh AV; Singh PK; Katoch K; Katoch VM
    Indian J Med Microbiol; 2018; 36(2):211-216. PubMed ID: 30084413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of
    Olivença F; Pires D; Silveiro C; Gama B; Holtreman F; Anes E; Catalão MJ
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0158623. PubMed ID: 38411952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methods.
    Miyata M; Pavan FR; Sato DN; Marino LB; Hirata MH; Cardoso RF; de Melo FA; Zanelli CF; Leite CQ
    Biomed Pharmacother; 2011 Sep; 65(6):456-9. PubMed ID: 21880463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
    Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
    Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Nimri L; Samara H; Batchoun R
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.